ArticleJournal of clinical medicine2020

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials.

Jordan M Cloyd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.